YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) Net margin 2021–2025
YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) net profit margin by fiscal year — reported net income divided by reported revenue.
-8736.7%FY2025 · since FY2021: -124.0% → -8736.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8736.7% | +42434.7 pp |
| FY2024 | -51171.4% | -50973.8 pp |
| FY2023 | -197.6% | +957.9 pp |
| FY2022 | -1155.5% | -1031.6 pp |
| FY2021 | -124.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More YBGJ financial trends
YBGJ RevenueYBGJ Net incomeYBGJ Gross profitYBGJ Gross marginYBGJ Operating incomeYBGJ Operating marginYBGJ Operating cash flowYBGJ Free cash flowYBGJ Capital expendituresYBGJ Return on equityYBGJ Stock buybacksYBGJ Dividends paidYBGJ Total assetsYBGJ Total liabilitiesYBGJ Shareholders’ equityYBGJ overview →